Apogee Therapeutics's market cap is currently $2.26B. The company's EPS TTM is $-1.13; its P/E ratio is ―; Apogee Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-1.19. See an overview of income statement, balance sheet, and cash flow financials.
